ACE Distinction in Endocrinology Award

2020 Winner

Meryl LeBoff, MD

headshot of Dr. LeBoff

Meryl S. LeBoff, MD, is a Professor of Medicine at Harvard Medical School (HMS) and the Brigham and Women’s Hospital (BWH), Distinguished Chair in Skeletal Health and Osteoporosis. She is Chief of the Calcium and Bone Section in the Division of Endocrinology, Diabetes and Hypertension at Brigham and Women’s Hospital (BWH) and directs the Skeletal Health and Osteoporosis Center and Bone Density Unit, which she founded. As an endocrinologist, Dr. LeBoff specializes in osteoporosis, fracture outcomes, metabolic bone diseases and disorders of calcium homeostasis. From evidence of a high prevalence of vitamin D deficiency in women admitted to BWH with hip fractures, she advanced the care of hip fracture patients with implementation of an inter-disciplinary fracture pathway with her colleagues in the Department of Orthopedic Surgery in what is now a Fracture Liaison service-Brigham Fracture Intervention Team pathway or “B-FIT©”.    

Dr. LeBoff’s research focuses on: bone health across the life cycle from young adulthood to extreme old age; vitamin D and bone health, fractures, musculoskeletal function and falls; risk factors for osteoporosis (including low vitamin D levels, hormonal modifiers on bone, and medical disorders or therapies that lead to low bone mass); and new approaches to imaging bone density and structure and body composition.  Dr. LeBoff was the contributing author to the Surgeon General’s Report on Bone Health and Osteoporosis on “Vitamin D intake across the life course”. She served on the central Calcium, Vitamin D, and Osteoporosis Committee for the large Women’s Health Initiative (WHI) since 1993 and WHI ancillary studies.  Dr. LeBoff served as a Council member for the American Society for Bone and Mineral Research. She serves on the Board of Trustees for the United States Bone and Joint Initiative and the National Osteoporosis Foundation.  In research grants sponsored by NIAMS.  She is the PI on two ancillary studies to the large vitamin D and OmegA-3 Fatty Acid Trial (VITAL), testing effects of supplemental vitamin D and /or omega-3 fatty acids vs. placebo on bone density and structure, body composition, physical performance measures and incident fractures in men and women.